Pro-inflammatory Chitosan/poly(γ-glutamic Acid) Nanoparticles Modulate Human Antigen-presenting Cells Phenotype and Revert Their Pro-invasive Capacity
Overview
Authors
Affiliations
Statement Of Significance: The immune system is responsible to detect and destroy abnormal cells preventing the development of cancer. However, the immunosuppressive tumor microenvironment can compromise the immune response favoring tumor progression. Thus, immune system modulation towards an immunostimulatory profile can improve anticancer therapies. This research focus on the development of chitosan/poly(γ-glutamic acid) nanoparticles (NPs) to modulate human antigen-presenting cells (APCs) phenotype and to counteract their pro-invasive capacity. Interestingly, Ch/γ-PGA NPs had a prominent effect in inducing macrophages and dendritic cells immunostimulatory phenotype, thus favoring T cell proliferation and inhibiting colorectal cancer cell invasion. We propose that their combination with other immunomodulatory drugs or conventional anticancer therapies can improve patients' outcome.
Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.
Li H, Wang S, Yang Z, Meng X, Niu M Bioact Mater. 2024; 36:376-412.
PMID: 38544737 PMC: 10965438. DOI: 10.1016/j.bioactmat.2024.03.003.
Drug delivery methods for cancer immunotherapy.
Perez-Herrero E, Lanier O, Krishnan N, DAndrea A, Peppas N Drug Deliv Transl Res. 2023; 14(1):30-61.
PMID: 37587290 PMC: 10746770. DOI: 10.1007/s13346-023-01405-9.
Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy.
Lian H, Ma S, Zhao D, Zhao W, Cui Y, Hua Y Pharmaceutics. 2022; 14(12).
PMID: 36559100 PMC: 9788370. DOI: 10.3390/pharmaceutics14122606.
Wei X, Wang J, Liang M, Song M Theranostics. 2022; 12(18):7821-7852.
PMID: 36451865 PMC: 9706587. DOI: 10.7150/thno.78572.
Antunes J, Domingues J, Miranda C, Silva A, Homem N, Amorim M Mar Drugs. 2021; 19(7).
PMID: 34201803 PMC: 8303307. DOI: 10.3390/md19070359.